nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0959	0.224	CbGbCtD
Eszopiclone—PTGS1—Etoposide—peripheral nervous system neoplasm	0.0699	0.163	CbGbCtD
Eszopiclone—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0669	0.156	CbGbCtD
Eszopiclone—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0418	0.0978	CbGbCtD
Eszopiclone—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0403	0.0943	CbGbCtD
Eszopiclone—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0389	0.0909	CbGbCtD
Eszopiclone—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0286	0.067	CbGbCtD
Eszopiclone—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0179	0.0417	CbGbCtD
Eszopiclone—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0164	0.0383	CbGbCtD
Eszopiclone—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0112	0.0261	CbGbCtD
Eszopiclone—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000271	0.000474	CcSEcCtD
Eszopiclone—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.000473	CcSEcCtD
Eszopiclone—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.000473	CcSEcCtD
Eszopiclone—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000473	CcSEcCtD
Eszopiclone—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000269	0.00047	CcSEcCtD
Eszopiclone—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000468	CcSEcCtD
Eszopiclone—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.000464	CcSEcCtD
Eszopiclone—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000266	0.000464	CcSEcCtD
Eszopiclone—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000265	0.000464	CcSEcCtD
Eszopiclone—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000264	0.000461	CcSEcCtD
Eszopiclone—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000264	0.000461	CcSEcCtD
Eszopiclone—Nausea—Topotecan—peripheral nervous system neoplasm	0.000264	0.000461	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000263	0.00046	CcSEcCtD
Eszopiclone—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000263	0.00046	CcSEcCtD
Eszopiclone—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000263	0.000459	CcSEcCtD
Eszopiclone—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000458	CcSEcCtD
Eszopiclone—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000262	0.000458	CcSEcCtD
Eszopiclone—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000262	0.000458	CcSEcCtD
Eszopiclone—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000261	0.000456	CcSEcCtD
Eszopiclone—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000456	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000259	0.000453	CcSEcCtD
Eszopiclone—Infection—Etoposide—peripheral nervous system neoplasm	0.000259	0.000453	CcSEcCtD
Eszopiclone—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.000452	CcSEcCtD
Eszopiclone—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000259	0.000452	CcSEcCtD
Eszopiclone—Nausea—Melphalan—peripheral nervous system neoplasm	0.000259	0.000452	CcSEcCtD
Eszopiclone—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000449	CcSEcCtD
Eszopiclone—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000449	CcSEcCtD
Eszopiclone—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000449	CcSEcCtD
Eszopiclone—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000447	CcSEcCtD
Eszopiclone—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000256	0.000447	CcSEcCtD
Eszopiclone—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000255	0.000445	CcSEcCtD
Eszopiclone—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000255	0.000445	CcSEcCtD
Eszopiclone—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000255	0.000445	CcSEcCtD
Eszopiclone—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000254	0.000443	CcSEcCtD
Eszopiclone—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000441	CcSEcCtD
Eszopiclone—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000252	0.000441	CcSEcCtD
Eszopiclone—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000438	CcSEcCtD
Eszopiclone—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000249	0.000434	CcSEcCtD
Eszopiclone—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000433	CcSEcCtD
Eszopiclone—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000248	0.000432	CcSEcCtD
Eszopiclone—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000432	CcSEcCtD
Eszopiclone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000247	0.000431	CcSEcCtD
Eszopiclone—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000246	0.00043	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000246	0.000429	CcSEcCtD
Eszopiclone—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000426	CcSEcCtD
Eszopiclone—Pain—Cisplatin—peripheral nervous system neoplasm	0.000243	0.000425	CcSEcCtD
Eszopiclone—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000424	CcSEcCtD
Eszopiclone—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.00024	0.00042	CcSEcCtD
Eszopiclone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00024	0.000419	CcSEcCtD
Eszopiclone—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000416	CcSEcCtD
Eszopiclone—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000416	CcSEcCtD
Eszopiclone—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000416	CcSEcCtD
Eszopiclone—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000415	CcSEcCtD
Eszopiclone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000237	0.000414	CcSEcCtD
Eszopiclone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000236	0.000413	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000235	0.00041	CcSEcCtD
Eszopiclone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000235	0.00041	CcSEcCtD
Eszopiclone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000234	0.000409	CcSEcCtD
Eszopiclone—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000409	CcSEcCtD
Eszopiclone—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000406	CcSEcCtD
Eszopiclone—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000233	0.000406	CcSEcCtD
Eszopiclone—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000232	0.000405	CcSEcCtD
Eszopiclone—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000231	0.000404	CcSEcCtD
Eszopiclone—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000229	0.0004	CcSEcCtD
Eszopiclone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000229	0.0004	CcSEcCtD
Eszopiclone—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.0004	CcSEcCtD
Eszopiclone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000229	0.000399	CcSEcCtD
Eszopiclone—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000227	0.000397	CcSEcCtD
Eszopiclone—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000227	0.000396	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000225	0.000393	CcSEcCtD
Eszopiclone—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000225	0.000393	CcSEcCtD
Eszopiclone—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000225	0.000393	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000393	CcSEcCtD
Eszopiclone—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000223	0.00039	CcSEcCtD
Eszopiclone—Pain—Etoposide—peripheral nervous system neoplasm	0.000223	0.00039	CcSEcCtD
Eszopiclone—Constipation—Etoposide—peripheral nervous system neoplasm	0.000223	0.00039	CcSEcCtD
Eszopiclone—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000389	CcSEcCtD
Eszopiclone—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000389	CcSEcCtD
Eszopiclone—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000389	CcSEcCtD
Eszopiclone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000221	0.000386	CcSEcCtD
Eszopiclone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00022	0.000385	CcSEcCtD
Eszopiclone—Sweating—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000384	CcSEcCtD
Eszopiclone—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.000384	CcSEcCtD
Eszopiclone—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000382	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000379	CcSEcCtD
Eszopiclone—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000378	CcSEcCtD
Eszopiclone—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000378	CcSEcCtD
Eszopiclone—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000376	CcSEcCtD
Eszopiclone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000215	0.000376	CcSEcCtD
Eszopiclone—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000214	0.000374	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000213	0.000373	CcSEcCtD
Eszopiclone—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000213	0.000372	CcSEcCtD
Eszopiclone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000212	0.000371	CcSEcCtD
Eszopiclone—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000371	CcSEcCtD
Eszopiclone—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000211	0.000368	CcSEcCtD
Eszopiclone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000211	0.000368	CcSEcCtD
Eszopiclone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00021	0.000366	CcSEcCtD
Eszopiclone—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000209	0.000366	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000363	CcSEcCtD
Eszopiclone—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000207	0.000362	CcSEcCtD
Eszopiclone—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000361	CcSEcCtD
Eszopiclone—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000206	0.00036	CcSEcCtD
Eszopiclone—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000206	0.00036	CcSEcCtD
Eszopiclone—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000206	0.00036	CcSEcCtD
Eszopiclone—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.00036	CcSEcCtD
Eszopiclone—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.00036	CcSEcCtD
Eszopiclone—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000206	0.00036	CcSEcCtD
Eszopiclone—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000358	CcSEcCtD
Eszopiclone—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000205	0.000358	CcSEcCtD
Eszopiclone—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000204	0.000357	CcSEcCtD
Eszopiclone—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000357	CcSEcCtD
Eszopiclone—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000355	CcSEcCtD
Eszopiclone—Rash—Vincristine—peripheral nervous system neoplasm	0.000203	0.000355	CcSEcCtD
Eszopiclone—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000203	0.000354	CcSEcCtD
Eszopiclone—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000354	CcSEcCtD
Eszopiclone—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000353	CcSEcCtD
Eszopiclone—Headache—Vincristine—peripheral nervous system neoplasm	0.000202	0.000352	CcSEcCtD
Eszopiclone—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.00035	CcSEcCtD
Eszopiclone—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000198	0.000347	CcSEcCtD
Eszopiclone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000195	0.00034	CcSEcCtD
Eszopiclone—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000195	0.00034	CcSEcCtD
Eszopiclone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000192	0.000336	CcSEcCtD
Eszopiclone—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000335	CcSEcCtD
Eszopiclone—Nausea—Vincristine—peripheral nervous system neoplasm	0.000191	0.000334	CcSEcCtD
Eszopiclone—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000334	CcSEcCtD
Eszopiclone—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000333	CcSEcCtD
Eszopiclone—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000331	CcSEcCtD
Eszopiclone—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.00033	CcSEcCtD
Eszopiclone—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000328	CcSEcCtD
Eszopiclone—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000187	0.000327	CcSEcCtD
Eszopiclone—Chills—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000323	CcSEcCtD
Eszopiclone—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000185	0.000322	CcSEcCtD
Eszopiclone—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000318	CcSEcCtD
Eszopiclone—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000181	0.000316	CcSEcCtD
Eszopiclone—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000315	CcSEcCtD
Eszopiclone—Rash—Cisplatin—peripheral nervous system neoplasm	0.00018	0.000314	CcSEcCtD
Eszopiclone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000179	0.000313	CcSEcCtD
Eszopiclone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000178	0.000312	CcSEcCtD
Eszopiclone—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.00031	CcSEcCtD
Eszopiclone—Tension—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000307	CcSEcCtD
Eszopiclone—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000306	CcSEcCtD
Eszopiclone—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000304	CcSEcCtD
Eszopiclone—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000303	CcSEcCtD
Eszopiclone—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000172	0.000301	CcSEcCtD
Eszopiclone—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000301	CcSEcCtD
Eszopiclone—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000298	CcSEcCtD
Eszopiclone—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000169	0.000295	CcSEcCtD
Eszopiclone—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000295	CcSEcCtD
Eszopiclone—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000294	CcSEcCtD
Eszopiclone—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000166	0.00029	CcSEcCtD
Eszopiclone—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000166	0.00029	CcSEcCtD
Eszopiclone—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000289	CcSEcCtD
Eszopiclone—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000288	CcSEcCtD
Eszopiclone—Rash—Etoposide—peripheral nervous system neoplasm	0.000164	0.000287	CcSEcCtD
Eszopiclone—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000164	0.000287	CcSEcCtD
Eszopiclone—Headache—Etoposide—peripheral nervous system neoplasm	0.000163	0.000285	CcSEcCtD
Eszopiclone—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000284	CcSEcCtD
Eszopiclone—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000284	CcSEcCtD
Eszopiclone—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000282	CcSEcCtD
Eszopiclone—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000281	CcSEcCtD
Eszopiclone—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000281	CcSEcCtD
Eszopiclone—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.00028	CcSEcCtD
Eszopiclone—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000278	CcSEcCtD
Eszopiclone—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000277	CcSEcCtD
Eszopiclone—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000273	CcSEcCtD
Eszopiclone—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000271	CcSEcCtD
Eszopiclone—Nausea—Etoposide—peripheral nervous system neoplasm	0.000155	0.000271	CcSEcCtD
Eszopiclone—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000155	0.00027	CcSEcCtD
Eszopiclone—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000269	CcSEcCtD
Eszopiclone—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000268	CcSEcCtD
Eszopiclone—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000266	CcSEcCtD
Eszopiclone—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000266	CcSEcCtD
Eszopiclone—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000266	CcSEcCtD
Eszopiclone—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000266	CcSEcCtD
Eszopiclone—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000263	CcSEcCtD
Eszopiclone—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000261	CcSEcCtD
Eszopiclone—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000261	CcSEcCtD
Eszopiclone—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.00026	CcSEcCtD
Eszopiclone—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000258	CcSEcCtD
Eszopiclone—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000256	CcSEcCtD
Eszopiclone—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000255	CcSEcCtD
Eszopiclone—Infection—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000254	CcSEcCtD
Eszopiclone—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000251	CcSEcCtD
Eszopiclone—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.00025	CcSEcCtD
Eszopiclone—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000249	CcSEcCtD
Eszopiclone—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000247	CcSEcCtD
Eszopiclone—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000247	CcSEcCtD
Eszopiclone—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000247	CcSEcCtD
Eszopiclone—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000246	CcSEcCtD
Eszopiclone—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000244	CcSEcCtD
Eszopiclone—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000243	CcSEcCtD
Eszopiclone—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000241	CcSEcCtD
Eszopiclone—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000238	CcSEcCtD
Eszopiclone—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000236	CcSEcCtD
Eszopiclone—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000235	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000233	CcSEcCtD
Eszopiclone—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000231	CcSEcCtD
Eszopiclone—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000231	CcSEcCtD
Eszopiclone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000229	CcSEcCtD
Eszopiclone—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000228	CcSEcCtD
Eszopiclone—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000228	CcSEcCtD
Eszopiclone—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000227	CcSEcCtD
Eszopiclone—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000225	CcSEcCtD
Eszopiclone—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000225	CcSEcCtD
Eszopiclone—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000222	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000221	CcSEcCtD
Eszopiclone—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000126	0.00022	CcSEcCtD
Eszopiclone—Pain—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000218	CcSEcCtD
Eszopiclone—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000218	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000215	CcSEcCtD
Eszopiclone—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000214	CcSEcCtD
Eszopiclone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000212	CcSEcCtD
Eszopiclone—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000211	CcSEcCtD
Eszopiclone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.00012	0.00021	CcSEcCtD
Eszopiclone—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.00021	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000209	CcSEcCtD
Eszopiclone—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000208	CcSEcCtD
Eszopiclone—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000205	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000204	CcSEcCtD
Eszopiclone—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000204	CcSEcCtD
Eszopiclone—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000203	CcSEcCtD
Eszopiclone—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000202	CcSEcCtD
Eszopiclone—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000202	CcSEcCtD
Eszopiclone—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000202	CcSEcCtD
Eszopiclone—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000202	CcSEcCtD
Eszopiclone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000195	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000193	CcSEcCtD
Eszopiclone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000188	CcSEcCtD
Eszopiclone—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000188	CcSEcCtD
Eszopiclone—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000187	CcSEcCtD
Eszopiclone—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000187	CcSEcCtD
Eszopiclone—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000183	CcSEcCtD
Eszopiclone—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000181	CcSEcCtD
Eszopiclone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000175	CcSEcCtD
Eszopiclone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	9.97e-05	0.000174	CcSEcCtD
Eszopiclone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	9.71e-05	0.00017	CcSEcCtD
Eszopiclone—Dizziness—Epirubicin—peripheral nervous system neoplasm	9.67e-05	0.000169	CcSEcCtD
Eszopiclone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	9.57e-05	0.000167	CcSEcCtD
Eszopiclone—Vomiting—Epirubicin—peripheral nervous system neoplasm	9.3e-05	0.000162	CcSEcCtD
Eszopiclone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	9.26e-05	0.000162	CcSEcCtD
Eszopiclone—Rash—Epirubicin—peripheral nervous system neoplasm	9.22e-05	0.000161	CcSEcCtD
Eszopiclone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	9.21e-05	0.000161	CcSEcCtD
Eszopiclone—Headache—Epirubicin—peripheral nervous system neoplasm	9.16e-05	0.00016	CcSEcCtD
Eszopiclone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	8.95e-05	0.000156	CcSEcCtD
Eszopiclone—Nausea—Epirubicin—peripheral nervous system neoplasm	8.69e-05	0.000152	CcSEcCtD
Eszopiclone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	8.6e-05	0.00015	CcSEcCtD
Eszopiclone—Rash—Doxorubicin—peripheral nervous system neoplasm	8.53e-05	0.000149	CcSEcCtD
Eszopiclone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	8.52e-05	0.000149	CcSEcCtD
Eszopiclone—Headache—Doxorubicin—peripheral nervous system neoplasm	8.48e-05	0.000148	CcSEcCtD
Eszopiclone—Nausea—Doxorubicin—peripheral nervous system neoplasm	8.04e-05	0.00014	CcSEcCtD
